India preparing to become hub for medical technology: Pharmaceuticals Secretary
Government policies and competitive industry driving India’s MedTech sector for sustained double-digit growth
Government policies and competitive industry driving India’s MedTech sector for sustained double-digit growth
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
Deepak has around 25 years of work experience with reputed companies viz. UPL Group, Teva Group, AkzoNobel India, Ranbaxy Laboratories, and Dr. Reddy’s Laboratories
India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
In financial year 2024-25, PMBJP has made sales of Rs. 1,760 crore (at MRP) till Feb 2025
The scheme is fully digitized and covers approximately 45% of India's population
Subscribe To Our Newsletter & Stay Updated